Clostridium difficile colonization in preoperative colorectal cancer patients Journal Article


Authors: Zheng, Y.; Luo, Y.; Lv, Y.; Huang, C.; Sheng, Q.; Zhao, P.; Ye, J.; Jiang, W.; Liu, L.; Song, X.; Tong, Z.; Chen, W.; Lin, J.; Tang, Y. W.; Jin, D.; Fang, W.
Article Title: Clostridium difficile colonization in preoperative colorectal cancer patients
Abstract: The entire process of Clostridium difficile colonization to infection develops in large intestine. However, the real colonization pattern of C. difficile in preoperative colorectal cancer patients has not been studied. In this study, 33 C. difficile strains (16.1%) were isolated from stool samples of 205 preoperative colorectal cancer patients. C. difficile colonization rates in lymph node metastasis patients (22.3%) were significantly higher than lymph node negative patients (10.8%) (OR=2.314, 95%CI=1.023-5.235, P =0.025). Meanwhile, patients positive for stool occult blood had lower C. difficile colonization rates than negative patients (11.5% vs. 24.0%, OR=0.300, 95%CI=0.131-0.685, P =0.019). A total of 16 sequence types were revealed by multilocus sequence typing. Minimum spanning tree and time-space cluster analysis indicated that all C. difficile isolates were epidemiologically unrelated. Antibiotic susceptibility testing showed all isolates were susceptible to vancomycin and metronidazole. The results suggested that the prevalence of C. difficile colonization is high in preoperative colorectal cancer patients, and the colonization is not acquired in the hospital. Since lymph node metastasis colorectal cancer patients inevitably require adjuvant chemotherapy and C. difficile infection may halt the ongoing treatment, the call for sustained monitoring of C. difficile in those patients is apparently urgent.
Keywords: colorectal cancer; epidemiology; clostridium difficile; colonization; transmission
Journal Title: Oncotarget
Volume: 8
Issue: 7
ISSN: 1949-2553
Publisher: Impact Journals  
Date Published: 2017-01-01
Start Page: 11877
End Page: 11886
Language: English
DOI: 10.18632/oncotarget.14424
PROVIDER: scopus
PUBMED: 28060753
PMCID: PMC5355311
DOI/URL:
Notes: Article -- Export Date: 2 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yi-Wei Tang
    188 Tang